Wobble Genomics is using full-length RNA sequencing from blood to detect novel biomarkers that have the potential to revolutionise cancer medicine.
- Investment status Current
- Invested 2023
- Category Health & Life Sciences
Wobble Genomics is using full-length RNA sequencing from blood to detect novel biomarkers that have the potential to revolutionise cancer medicine.